Dermatology | Jotup

all® Laundry Detergent Brand Announces all® sensitive fresh™, a 2024 'Product of the Year USA' Winner

Retrieved on:

Wednesday, April 10, 2024

Target, Walmart, EPA, State, Skin, Marketing, Pollen, Dermatology, Pediatrics, 1¹¹=1 (Power of Destiny), Allergy, Perfume

STAMFORD, Conn., April 10, 2024 /PRNewswire/ -- The makers of all® free clear—the #1 detergent brand recommended by dermatologists, allergists and pediatricians for sensitive skin—today announced a new addition to its lineup of laundry products, all® sensitive fresh™. all® sensitive fresh™ was developed with a "Spring Breeze" hypoallergenic scent, is 100% free of dyes and removes 99% of top every day and seasonal allergens*. Already receiving high praise, the new detergent was recently named a 2024 winner of the largest consumer-voted awards program centered around product innovation, Product of the Year USA—a survey of 40,000 people by Kantar—in the laundry detergent category.

Key Points:

Already receiving high praise, the new detergent was recently named a 2024 winner of the largest consumer-voted awards program centered around product innovation, Product of the Year USA —a survey of 40,000 people by Kantar—in the laundry detergent category.
"The all® brand is committed to developing laundry products that meet the needs of all consumers," said Julia Galotto, Vice President of Marketing at Henkel.
The laundry detergent will be available at Walmart, Target and other national retailers in-store and online later this month.
all® sensitive fresh™ joins a diverse portfolio of all® laundry detergent products made to address an array of sensitive skin laundry needs including liquid laundry detergent, mighty pacs®, fabric softener and dryer sheets.

UCB Launches Make HStory, an Educational Campaign Offering Resources and Support for Those Living with Hidradenitis Suppurativa

Retrieved on:

Wednesday, April 10, 2024

Social media, Hope, HS, Hidradenitis suppurativa, Partnership, Disease, Dermatology, UCB, Patient, Inflammation, Diagnosis, Health, Make

"My UCB colleagues and I are incredibly grateful to those who have already shared their HS journeys and stories as part of the Make HStory campaign.

Key Points:

"My UCB colleagues and I are incredibly grateful to those who have already shared their HS journeys and stories as part of the Make HStory campaign.
Their own experiences and personal histories are what will provide hope and a path forward for so many others."
UCB is proud to contribute to advancing the understanding of HS and is committed to continuing its mission to address unmet needs for those living with this severe disease.
To stay up to date on the latest HS resources, visit https://www.makehstory.com/ and follow Make HStory on Instagram at @MakeHStory and on Facebook at www.facebook.com/makehstory .

U.S. Dermatology Partners Announces the Opening of Second Granbury, Texas Office

Retrieved on:

Wednesday, April 10, 2024

Dermatitis, Outreach, Partner, Acne, Private practice, Skin cancer, Dermatology, Patient, Psoriasis, Hospital

GRANBURY, Texas, April 10, 2024 /PRNewswire-PRWeb/ -- U.S. Dermatology Partners is pleased to announce the opening of a second office location in Granbury, Texas. This new location will help support the growing need for dermatologic care in the Hood County community. The organization's first office in Granbury has been serving the area since June 2022 and has drawn patients from a wide radius around Granbury. The new office is the latest addition to the organization's Outreach Program which is committed to serving rural and underserved communities. To improve access to professional dermatologic care in rural areas, U.S. Dermatology Partners has launched more than 30 new locations across eight states over the past few years. These new offices, including the new Granbury location, will provide patients with more convenient access to the care they need and deserve. Beginning April 8th, the office will extend convenient access to dermatology and skin cancer treatments for patients in Hood County. The new facility will provide care for various dermatologic conditions, including acne, psoriasis, eczema, and skin cancer.

Key Points:

U.S. Dermatology Partners expands access to dermatology care to patients in Hood County with the opening of a second office location.
GRANBURY, Texas, April 10, 2024 /PRNewswire-PRWeb/ -- U.S. Dermatology Partners is pleased to announce the opening of a second office location in Granbury, Texas .
Beginning April 8th, the office will extend convenient access to dermatology and skin cancer treatments for patients in Hood County.
Today's announcement builds on U.S. Dermatology Partners' recent openings of offices in Alva, Oklahoma, Kaufman, Texas, and Peoria, Arizona.

The Cigna Group Named Among Best Employers for Health and Well-Being

Retrieved on:

Tuesday, April 9, 2024

Organization, Health equity, Culture, Mental health, Job satisfaction, Workforce, Dermatology, Meditation

BLOOMFIELD, Conn., April 9, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) has been recognized for excellence in employee health and well-being by the Business Group on Health, and for its commitment to health equity. This marks the 17th consecutive year the company has been recognized for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives.

Key Points:

BLOOMFIELD, Conn., April 9, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) has been recognized for excellence in employee health and well-being by the Business Group on Health, and for its commitment to health equity.
"We believe that employers play a vital role in the health care system, and we strive to be a model for others by prioritizing the health and vitality of employees within our own company," said Kari Knight Stevens, chief human resource officer, The Cigna Group.
"A healthy and diverse workforce is essential to achieving our mission, and we continually invest in our employees to support their health and vitality."
The Business Group on Health assesses organizations based on their approach to leadership, strategy, and culture; holistic well-being, including mental health, financial security, physical health, social connectedness, and job satisfaction; engagement and the employee experience; health equity; and metrics and evaluation.

EQS-News: Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business

Retrieved on:

Wednesday, April 10, 2024

Annual, Annual report, Tax, BioNTech, Coronavirus, Inflammation, Acquisition, Management, Dermatology, Depreciation, Pain, Growth, Parallel, Pharmaceutical industry

Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business

Key Points:

Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
The issuer is solely responsible for the content of this announcement.
» Adjusted consolidated EBITDA margin: 27.3%
Grünwald, 14 March 2024 – Dermapharm Holding SE ("Dermapharm"), a rapidly growing manufacturer of branded pharmaceuticals and other healthcare products, today publishes its unaudited preliminary consolidated figures (IFRS) for financial year 2023.
Adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) declined by 13.8% to EUR 310.2 million (prior-year period: EUR 359.8 million).
We exceeded our guidance for consolidated revenue and reached the upper end of the forecast range for adjusted EBITDA.

Olansky Dermatology & Aesthetics welcomes physician assistant, expands hours

Retrieved on:

Tuesday, April 9, 2024

Psoriasis, Skin cancer, Patient, Mohs surgery, Aesthetics, Quality of life, Suite, Dermatology, Acne, Family

ATLANTA, April 09, 2024 (GLOBE NEWSWIRE) -- Olansky Dermatology & Aesthetics –Georgia’s top-rated dermatology practice– welcomes physician assistant Kathryn “Katie” Shea to its Buckhead location.

Key Points:

ATLANTA, April 09, 2024 (GLOBE NEWSWIRE) -- Olansky Dermatology & Aesthetics –Georgia’s top-rated dermatology practice– welcomes physician assistant Kathryn “Katie” Shea to its Buckhead location.
This addition to the practice’s acclaimed staff allows Olansky Dermatology & Aesthetics the ability to offer new, expanded hours at its Buckhead location, a first for Atlanta area dermatology.
She has extensive experience in dermatology and urgent care medicine, and she is a member of the Georgia Association of Physician Assistants, American Academy of Physician Assistants, and Georgia Dermatology Physician Assistants.
“We strive to offer our patients the best providers possible,” says Dr. Jodi Ganz, physician partner at Olansky Dermatology & Aesthetics, “By growing our staff, it allows us to better meet patients where they are and provide additional hours for better flexibility.”
Olansky Dermatology & Aesthetics is your dermatology solution.

STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan

Retrieved on:

Tuesday, April 9, 2024

SSKN, Dermatology, Marketing, Pharmaceutical industry

HORSHAM, Pa., April 09, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces the renewal of two distinct distribution agreements in international territories – one with the current exclusive distributor in China and a second with the current exclusive distributor in Japan.

Key Points:

HORSHAM, Pa., April 09, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces the renewal of two distinct distribution agreements in international territories – one with the current exclusive distributor in China and a second with the current exclusive distributor in Japan.
Terms of each of the distribution agreements are for three years and carry minimum unit placements and/or purchases of the XTRAC and VTRAC devices.
“The renewal of these exclusive distribution agreements in China and Japan, when coupled with the renewal of the distribution agreement in South Korea announced in December 2023, brings improved visibility to the international segment of our business,” stated Dr. Dolev Rafaeli, STRATA’s President and Chief Executive Officer.
We look forward to continued mutually beneficial relations with each and leveraging our installed base around the world, as service and parts sales are an important aspect of our international business.”

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against InMode, Innodata, Fox Factory, and X and Encourages Investors to Contact the Firm

Retrieved on:

Monday, April 8, 2024

InMode is a global provider of aesthetic medical devices and technology, including devices purporting to offer body sculpting and other rejuvenation technologies.

Key Points:

InMode is a global provider of aesthetic medical devices and technology, including devices purporting to offer body sculpting and other rejuvenation technologies.
Specifically, Defendants repeatedly touted the demand for InMode’s devices and told investors that those devices were never sold at a discount.
The complaint further alleges that when these misleading statements and omissions about Fox Factory’s business reached the market, investors were harmed significantly.
For more information on the Palo Alto Networks class action go to: https://bespc.com/cases/PANW

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NYCB, InMode, Innodata, and Fox Factory and Encourages Investors to Contact the Firm

Retrieved on:

Wednesday, April 3, 2024

NYCB is a large commercial-real estate lender in the New York City market area, where it specializes in rent-regulated, non-luxury apartment buildings.

Key Points:

NYCB is a large commercial-real estate lender in the New York City market area, where it specializes in rent-regulated, non-luxury apartment buildings.
On January 31, 2024, before the market opened, NYCB announced its fiscal fourth quarter 2023 financial results.
The complaint further alleges that when these misleading statements and omissions about Fox Factory’s business reached the market, investors were harmed significantly.
For more information on the Fox Factory class action go to: https://bespc.com/cases/FOXF

INMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on:

Wednesday, April 3, 2024

Food and Drug Administration, Dermatology, Complaint, Confidentiality, Injury, Dentist, FDA, Court, Person

InMode is a global provider of aesthetic medical devices and technology including devices purporting to offer body sculpting and other rejuvenation technologies.

Key Points:

InMode is a global provider of aesthetic medical devices and technology including devices purporting to offer body sculpting and other rejuvenation technologies.
Specifically, Defendants repeatedly touted the demand for InMode’s devices and told investors that those devices were never sold at a discount.
or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.